BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17113799)

  • 1. Blastic natural killer cell leukaemia in a dog--a case report.
    Bonkobara M; Saito T; Yamashita M; Tamura K; Yagihara H; Isotani M; Sato T; Washizu T
    Vet J; 2007 Nov; 174(3):659-62. PubMed ID: 17113799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large granular lymphocytic leukaemia pathogenesis and management.
    Dearden C
    Br J Haematol; 2011 Feb; 152(3):273-83. PubMed ID: 21158751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell large granular lymphocytic leukaemia: successful response to 2-deoxycoformycin.
    Dincol G; Diz-Kuçukkaya R; Bicakci E
    Neth J Med; 2008 Feb; 66(2):85-7. PubMed ID: 18292613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myelomonocytic leukemia in a dog.
    Rohrig KE
    J Am Vet Med Assoc; 1983 Jan; 182(2):137-41. PubMed ID: 6572189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large granular lymphocytic leukaemia complicated with histiocytic sarcoma in a dog.
    Maruo T; Namikawa K; Kunihiro A; Lynch J; Shida T; Kishikawa S
    J S Afr Vet Assoc; 2009 Dec; 80(4):261-3. PubMed ID: 20458870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous acute erythroblastic leukaemia (AML-M6Er) in a dog.
    Tomiyasu H; Fujino Y; Takahashi M; Ohno K; Tsujimoto H
    J Small Anim Pract; 2011 Aug; 52(8):445-7. PubMed ID: 21797877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastic natural killer (NK) cell leukemia (agranular CD4+CD56+ leukemia).
    Zhang K; Prichard JW; Brown RE
    Ann Clin Lab Sci; 2006; 36(2):212-5. PubMed ID: 16682521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in understanding and managing natural killer-cell malignancies.
    Oshimi K
    Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
    Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
    J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of blastic NK-cell lymphoma.
    Akasaka E; Mabuchi T; Umezawa Y; Iwashita K; Ohta Y; Matsuyama T; Ozawa A
    Int J Dermatol; 2007 Jul; 46(7):722-6. PubMed ID: 17614802
    [No Abstract]   [Full Text] [Related]  

  • 11. CD5-low expression lymphocytes in canine peripheral blood show characteristics of natural killer cells.
    Huang YC; Hung SW; Jan TR; Liao KW; Cheng CH; Wang YS; Chu RM
    J Leukoc Biol; 2008 Dec; 84(6):1501-10. PubMed ID: 18708592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients.
    Akiyama T; Okino T; Konishi H; Wani Y; Notohara K; Tsukayama C; Tsunoda T; Tasaka T; Masaki Y; Sugihara T; Sadahira Y
    Pathol Int; 2008 Oct; 58(10):626-34. PubMed ID: 18801082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
    Tan DB; Fernandez S; French M; Price P
    Clin Immunol; 2009 Jul; 132(1):63-70. PubMed ID: 19403337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc improves the development of human CD34+ cell progenitors towards Natural Killer cells and induces the expression of GATA-3 transcription factor.
    Muzzioli M; Stecconi R; Donnini A; Re F; Provinciali M
    Int J Biochem Cell Biol; 2007; 39(5):955-65. PubMed ID: 17306601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
    Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
    Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
    Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic and molecular aspects of CD56+ natural killer/ T-cell lymphoma of the testis.
    Ornstein DL; Bifulco CB; Braddock DT; Howe JG
    Int J Surg Pathol; 2008 Jul; 16(3):291-300. PubMed ID: 18573785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction.
    Yamazaki J; Baba K; Goto-Koshino Y; Setoguchi-Mukai A; Fujino Y; Ohno K; Tsujimoto H
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):321-31. PubMed ID: 18977540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.